IS8099A - Lyfjablanda sem inniheldur módafíníl og annað lyf - Google Patents

Lyfjablanda sem inniheldur módafíníl og annað lyf

Info

Publication number
IS8099A
IS8099A IS8099A IS8099A IS8099A IS 8099 A IS8099 A IS 8099A IS 8099 A IS8099 A IS 8099A IS 8099 A IS8099 A IS 8099A IS 8099 A IS8099 A IS 8099A
Authority
IS
Iceland
Prior art keywords
medicinal
product containing
products
containing modafinil
modafinil
Prior art date
Application number
IS8099A
Other languages
English (en)
Inventor
J. Hughes Rodney
L. Vaught Jeffrey
Original Assignee
Cephalon, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon, Inc. filed Critical Cephalon, Inc.
Publication of IS8099A publication Critical patent/IS8099A/is

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IS8099A 2003-05-16 2005-10-27 Lyfjablanda sem inniheldur módafíníl og annað lyf IS8099A (is)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US47130203P 2003-05-16 2003-05-16
US10/845,836 US20040229943A1 (en) 2003-05-16 2004-05-14 Analeptic and drug combinations
PCT/US2004/015408 WO2004103359A1 (en) 2003-05-16 2004-05-17 Pharmaceutical combination comprising modafinil and another drug

Publications (1)

Publication Number Publication Date
IS8099A true IS8099A (is) 2005-10-27

Family

ID=33424098

Family Applications (1)

Application Number Title Priority Date Filing Date
IS8099A IS8099A (is) 2003-05-16 2005-10-27 Lyfjablanda sem inniheldur módafíníl og annað lyf

Country Status (14)

Country Link
US (1) US20040229943A1 (is)
EP (1) EP1635807A1 (is)
JP (1) JP2007506801A (is)
KR (1) KR20060015727A (is)
AU (1) AU2004241110A1 (is)
BR (1) BRPI0411176A (is)
CA (1) CA2524870A1 (is)
EA (1) EA200501821A1 (is)
IS (1) IS8099A (is)
MX (1) MXPA05012358A (is)
MY (1) MY135829A (is)
NO (1) NO20055173L (is)
TW (1) TW200509896A (is)
WO (1) WO2004103359A1 (is)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101098749B1 (ko) * 2000-07-27 2011-12-23 테바 파마슈티컬 인더스트리즈 리미티드 결정질의 순수한 모다피닐 및 이의 제조 방법
US20070053976A1 (en) * 2002-05-17 2007-03-08 Eisai R & D Management Co., Ltd. Novel combination of drugs as antidepressant
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
WO2005099822A2 (en) * 2004-04-13 2005-10-27 Cephalon, Inc. Reduction of drug / drug interactions with modafinil
ATE488275T1 (de) * 2006-03-23 2010-12-15 Yissum Res Dev Co Verwendung von digitalis-artigen verbindungen bei der behandlung von affektiven störungen
DE102006015734A1 (de) * 2006-04-04 2007-10-11 Hermann, Holger Lars, Dr. Kombinationspräparate aus Modafinil, Ritalin und Topiramat und deren Derivaten zur Behandlung von Kokainabhängigkeit und/oder Impulskontrollstörung
RU2445953C2 (ru) * 2006-12-01 2012-03-27 Нитто Денко Корпорейшн Стабилизированная адгезивная композиция, содержащая донепезил
JP5110712B2 (ja) * 2006-12-01 2012-12-26 日東電工株式会社 ドネペジル含有貼付製剤の経時的な変色を抑制する方法
CN102046171B (zh) * 2008-05-30 2013-06-19 日东电工株式会社 经皮吸收制剂
RU2481826C2 (ru) * 2008-05-30 2013-05-20 Нитто Денко Корпорейшн Содержащий донепезил адгезивный препарат и упаковка для него
KR20120101588A (ko) * 2010-01-07 2012-09-13 비버스 인크. 탄산탈수효소 억제제 및 추가적인 활성제의 조합에 의한 폐쇄 수면 무호흡 증후군의 치료
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules
MA66991A1 (fr) * 2022-04-21 2025-03-28 Zevra Therapeutics, Inc. Composés d'administration de gamma-hydroxybutyrate et leurs procédés de préparation et méthodes d'utilisation
US11977085B1 (en) 2023-09-05 2024-05-07 Elan Ehrlich Date rape drug detection device and method of using same

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696153A (en) * 1994-05-16 1997-12-09 Napro Biotherapeutics, Inc. Therapeutic regimen for treating patients
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
AU6528400A (en) * 1999-08-23 2001-03-19 David M. Ockert Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
US20010034373A1 (en) * 2000-02-09 2001-10-25 Matthew Miller Low dose modafinil for enhancement of cognitive function
US6417184B1 (en) * 2000-09-19 2002-07-09 David M. Ockert Triple drug therapy for the treatment and prevention of acute or chronic pain
US20030036555A1 (en) * 2001-08-03 2003-02-20 Boehringer Ingelheim Pharma Kg Pramipexole for the treatment of ADHD
US20040242698A1 (en) * 2003-05-13 2004-12-02 Cephalon Inc. Analeptic and antidepressant combinations
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos

Also Published As

Publication number Publication date
US20040229943A1 (en) 2004-11-18
BRPI0411176A (pt) 2006-07-18
WO2004103359A1 (en) 2004-12-02
EA200501821A1 (ru) 2006-06-30
MY135829A (en) 2008-07-31
KR20060015727A (ko) 2006-02-20
AU2004241110A1 (en) 2004-12-02
TW200509896A (en) 2005-03-16
NO20055173L (no) 2005-12-12
NO20055173D0 (no) 2005-11-03
CA2524870A1 (en) 2004-12-02
EP1635807A1 (en) 2006-03-22
JP2007506801A (ja) 2007-03-22
MXPA05012358A (es) 2006-02-02

Similar Documents

Publication Publication Date Title
IS8099A (is) Lyfjablanda sem inniheldur módafíníl og annað lyf
IS7304A (is) Tvívetnissetin pýrasólýlbensýlsúlfónamíð og lyf sem innihalda téð efnasambönd
GB0303730D0 (en) Process and product
GB0214013D0 (en) Pharmaceutical product
EP1682538A4 (en) BIARYL-ASSOCIATED HYDROXAMATE: PREPARATION AND PHARMACEUTICAL APPLICATIONS
ATE427037T1 (de) Essbares produkt enthaltend probiotische kulturen
IL197159A0 (en) Rna molecules and pharmaceutical compositions containing the same
EP1615615A4 (en) PHARMACEUTICAL PRODUCTS
EP1447214A4 (en) MULTILAYER PRODUCTS BASED ON POLYIMIDE-METAL AND MULTILAYER PRODUCT BASED ON POLYAMIDEIMIDE-METAL
IL170758A0 (en) 7-amino-isoindolyl compounds and their pharmaceutical uses
PT1592426E (pt) 2-cianopirrolopirimidinas e seus usos farmacêuticos
AU2003290387A8 (en) Dietry supplements and foods product comprising oleylethanolamide
GB0303716D0 (en) Food product and process
IS7491A (is) Benzoxazínon-afleidd efnasambönd, framleiðsla þeirra og notkun sem lyf
DE60238504D1 (de) Gelkapseln oder tabletten enthaltendes nahrungsmittel
FI20030287L (fi) Polydekstroosin uusi käyttö syötävässä tuotteessa polydekstroosia sisältävät syötävät tuotteet ja menetelmät polydekstroosin sisällyttämiseksi syötäviin tuotteisiin
EP1542727A4 (en) PRODUCT REFRIGERATOR OF BREATH AND ORAL HYGIENE
GB0119068D0 (en) Shellfish product and process
EP1545448A4 (en) FRESHNESS AND MOUTH CLEANING PRODUCT WITH GERANIOL
GB0315889D0 (en) Stable pharmaceutical products
EP1691621A4 (en) MILK PRODUCT AND METHOD
FR2825004B1 (fr) Produit dietetique satiant
DE602004022402D1 (de) Extrusionsprozess und produkt
AP2005003317A0 (en) Product and method
AU2003251303A1 (en) Pharmaceutical products and methods of manufacture